Has been acquired by
FutureMatrix Interventional, Inc.
FutureMatrix Interventional, Inc. a privately held Texas Corporation. The company has operated in Athens, Texas since inception. The initial product FMxI developed and manufactured was a PTA Catheter. FMI has expertise in research, design and manufacturing of life saving and life-improving disposable medical devices such as balloon catheters and urological stents.
BioMerics specializes in the design, development, and production of medical devices for diagnostic and interventional procedures for the cardiovascular, structural heart, cardiac rhythm management, and vascular access markets. The company, formed in 2009, provides a full range of engineered components and finished devices to the world’s leading medical device OEMs.
This material has been prepared solely for informative purposes as of its stated date and is not a solicitation, or an offer, to buy or sell any security. It does not purport to be a complete description of the securities, markets or developments referred to in the material. Information included in the material was obtained from external sources which we consider reliable, but we have not independently verified such information and do not guarantee that it is accurate or complete. Such information is believed to be accurate on the date of issuance of the material. No subsequent publication or distribution of this material shall mean or imply that any such information or opinion remains current at any time after the stated date of the material. We do not undertake to advise you of any changes in any such information or opinion. Additional information is available upon request.
FirstSun Capital Bancorp and HomeStreet, Inc. Announce Transformational Strategic Merger